OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director exercised or converted 650 UTHR derivative securities | OQRO

Home
Insider trades
United Therapeutics
Director exercised or converted 650 UTHR derivative securities

Insider trades

Insider trade

Director exercised or converted 650 UTHR derivative securities

Traded Jul 9, 2026 · Filed Jul 14, 2026

UTHUnited TherapeuticsUTHR

650
Shares

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jul 9, 2026
Reporting period: Not applicable
Filed with the SEC: Jul 14, 2026

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001108501-26-000002

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Jul 14, 2026, 12:36 AM UTC

Added to OQRO

Oct 6, 2026, 9:34 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

UNITED THERAPEUTICS Corp

Issuer CIK

1082554

Ticker

UTHR

Reporting person

Ray Kurzweil

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Jul 9, 2026

Transaction code

Shares / units

650

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

13,320

Ownership form

Direct

Amendment

Footnotes from the filing

Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.

Around the same time

Martine A RothblattChairperson & CEO

Filed 8w ago

9,500Shares · @ $135.42

Traded Aug 11 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Martine A Rothblatt (Chairperson & CEO) sold ~$244K of United Therapeutics

Scheduled in advanceFiled 8w ago

Martine A Rothblatt (Chairperson & CEO) sold ~$625K of United Therapeutics

Scheduled in advanceFiled 8w ago